Skip to main content
. 2018 Feb 8;13(2):e0192220. doi: 10.1371/journal.pone.0192220

Table 1. Baseline characteristics of patient population.

Characteristics
Age (years) 59±10
Male, n(%) 44(88)
Cardiovascular risk factors, n(%)
Hypertension 19(38)
Diabetes 4(8)
Hypercholesterolemia 21(42)
Family history of CAD 22(44)
Current smoker 29(58)
Killip class I 49(98)
Laboratory parameters
Creatinine at admission (mg/dl) 0.93±0.23
eGFR at admission (ml/min/1.73mq) 93±25
Kalemia at admission (mEq/l) 3.86±0.45
Peak kalemia (mEq/l) 4.35±0.37
Peak troponin I (ng/mL) 50[18–112]
Medication at hospital admission
Beta-blockers 4(8.0)
ACEi/ARBs 13(26.0)
Diuretics 3(6.0)
Ca-antagonist 3(6.0)
Anticoagulants agents 3(6.0)
Nitrate 1(2.0)
Tricagrelor 13(26.0)
Prasugrel 30(60.0)
Clopidogrel 7(14.0)
Statins 3(6.0)
Aspirin 48(96.0)
Gp IIb/IIIa inhibitors 9(18.0)
Catheterization laboratory data
Time-to-PCI (min) 171[100–180]
Door-to-balloon time (min) 37[0–45]
Infarct-related artery, n(%)
Proximal LAD 26(52.0)
Single-vessel disease 31(62.0)
Double-vessel disease 14(28.0)
Triple-vessel disease 5(10.0)
Pre-PCI TIMI-flow grade, n(%)
0/1 46(92.0)
2/3 4(8.0)
Post-PCI TIMI-flow grade, n(%)
0/1 0
2/3 50(100)
Rentrop grade, n(%) 0
Medication at discharge, n(%)
ACE-i/ARBs 40(80.0)
Beta-blockers 48(96.0)
Statins 49(98.0)
Diuretics 6(12.0)
Ivabradine 3(6.0)
Ca-antagonists 2(4.0)
Anticoagulants 3(6.0)
Antithrombotic agents 49(98.0)
Nitrates 2(4.0)
Echocardiographic data
LVEDVi, ml/m2 50±12
LVESVi, ml/m2 26±8
LVEF,% 49±8
N° of segments with wall motion abnormalities 7±3
TAPSE, mm 22±3
PAP, mmHg 26±8

ACE: angiotensin converting enzyme; ARB: angiotensin receptor blockade; CAD: coronary artery disease; eGFR: estimated glomerular filtration rate; GP: glycoprotein; LAD: left anterior descending artery; LVEDVi: indexed left ventricle end-diastolic volume; LVESVi: indexed left ventricle end-systolic volume; LVEF: left ventricle ejection fraction; PAP: pulmonary artery pressure; PCI: percutaneous coronary intervention; TAPSE: tricuspid annular plane systolic excursion.